Arcutis Biotherapeutics, Inc. (ARQT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1250457,
    "name": "Arcutis Biotherapeutics, Inc.",
    "stock_name": "Arcutis Biotherapeutics, Inc.",
    "full_name": "Arcutis Biotherapeutics, Inc.",
    "name_url": "stocks-analysis/arcutis-biotherapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "31.16",
    "chg": 1.73,
    "chgp": "5.88%",
    "dir": 1,
    "prev_price": "29.43",
    "mcapval": "2,080.24",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03969K1088",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.44 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arcutis-biotherapeutics-inc-1250457-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arcutis Biotherapeutics Achieves 186.45% Return, Establishing It as a Multibagger in Biotechnology",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-achieves-18645-return-establishing-it-as-a-multibagger-in-biotechnology-3658963",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_multibagger_3658963.png",
        "date": "2025-10-29 15:12:30",
        "description": "Arcutis Biotherapeutics, Inc. has recently undergone a revision in its score, reflecting its impressive performance in the Pharmaceuticals & Biotechnology sector. The company has achieved significant returns over the past year and demonstrated strong momentum, underscoring its robust market position and growth potential."
      },
      {
        "title": "Arcutis Biotherapeutics Hits New 52-Week High of $21.71, Soars 186.87%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-new-52-week-high-of-2171-soars-18687-3626672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3626672.png",
        "date": "2025-10-16 18:28:11",
        "description": "Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company reported substantial growth in net sales and has maintained positive results for seven consecutive quarters, despite operating at a loss. High institutional holdings indicate strong investor confidence."
      },
      {
        "title": "Arcutis Biotherapeutics Hits New 52-Week High of $21.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-new-52-week-high-of-2155-3608079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3608079.png",
        "date": "2025-10-09 20:26:20",
        "description": "Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a remarkable performance with a substantial increase over the past year. The company has shown strong financial growth, positive quarterly results, and high institutional ownership, despite being loss-making, indicating confidence in its operational capabilities."
      },
      {
        "title": "Arcutis Biotherapeutics Hits New 52-Week High of $21.30",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-new-52-week-high-of-2130-3595685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3595685.png",
        "date": "2025-10-06 17:42:29",
        "description": "Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting significant growth with a 164.13% increase in net sales and seven consecutive quarters of positive results. Despite operating losses, the company shows resilience with strong cash flow and full institutional backing, highlighting its competitive industry position."
      },
      {
        "title": "Arcutis Biotherapeutics Hits New 52-Week High of $20.10, Up 162%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-new-52-week-high-of-2010-up-162-3588414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3588414.png",
        "date": "2025-10-02 22:41:22",
        "description": "Arcutis Biotherapeutics, Inc. achieved a new 52-week high of USD 20.10 on October 1, 2025, reflecting a significant performance increase over the past year. The company reported a 164.13% surge in net sales and has shown consistent growth with seven consecutive quarters of positive results."
      },
      {
        "title": "Arcutis Biotherapeutics Achieves 101.39% Stock Surge, Establishing It as a Multibagger Performer",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-achieves-10139-stock-surge-establishing-it-as-a-multibagger-performer-3586550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_multibagger_3586550.png",
        "date": "2025-10-01 17:13:44",
        "description": "Arcutis Biotherapeutics, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The company has achieved significant growth in net sales and operating cash flow, showcasing its operational strength and resilience in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Arcutis Biotherapeutics Hits New 52-Week High of $19.36",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-new-52-week-high-of-1936-3586087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3586087.png",
        "date": "2025-10-01 16:44:40",
        "description": "Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 2,080 million, has shown strong growth metrics, including a notable rise in net sales and consistent positive results over seven quarters."
      },
      {
        "title": "Arcutis Biotherapeutics Hits Day High with Strong 7.29% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcutis-biotherapeutics-hits-day-high-with-strong-729-intraday-surge-3585925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcutisBiothera_priceRelatedfactors_3585925.png",
        "date": "2025-10-01 16:21:56",
        "description": "Arcutis Biotherapeutics, Inc. has shown impressive stock performance, with significant gains over various timeframes. The company reported a substantial increase in net sales and has achieved positive results for seven consecutive quarters. High institutional holdings further enhance its market position within the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Is Arcutis Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcutis-biotherapeutics-inc-technically-bullish-or-bearish-3547999",
        "imagepath": "",
        "date": "2025-09-20 20:07:38",
        "description": "As of 12 August 2025, the technical trend for Arcutis Biotherapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view: the MACD is bullish on both weekly and monthly time frames, Bollinger Bands are bullish, and the On-Balance Volume (OBV) is also bullish. The daily moving averages confirm this bullish trend. However, the Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. \n\nIn terms of performance, Arcutis has outperformed the S&P 500 over the past week (0.11% vs. 1.05%), month (5.79% vs. 2.33%), year-to-date (27.14% vs. 12.22%), and year (70.29% vs. 17.14%). However, it has underperformed over the longer 3-year and 5-year periods...."
      }
    ],
    "total": 15,
    "sid": "1250457",
    "stock_news_url": "https://www.marketsmojo.com/news/arcutis-biotherapeutics-inc-1250457"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Arcutis Biotherapeutics Achieves 186.45% Return, Establishing It as a Multibagger in Biotechnology

2025-10-29 15:12:30

Arcutis Biotherapeutics, Inc. has recently undergone a revision in its score, reflecting its impressive performance in the Pharmaceuticals & Biotechnology sector. The company has achieved significant returns over the past year and demonstrated strong momentum, underscoring its robust market position and growth potential.

Arcutis Biotherapeutics Hits New 52-Week High of $21.71, Soars 186.87%

2025-10-16 18:28:11

Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company reported substantial growth in net sales and has maintained positive results for seven consecutive quarters, despite operating at a loss. High institutional holdings indicate strong investor confidence.

Arcutis Biotherapeutics Hits New 52-Week High of $21.55

2025-10-09 20:26:20

Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a remarkable performance with a substantial increase over the past year. The company has shown strong financial growth, positive quarterly results, and high institutional ownership, despite being loss-making, indicating confidence in its operational capabilities.

Arcutis Biotherapeutics Hits New 52-Week High of $21.30

2025-10-06 17:42:29

Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting significant growth with a 164.13% increase in net sales and seven consecutive quarters of positive results. Despite operating losses, the company shows resilience with strong cash flow and full institutional backing, highlighting its competitive industry position.

Arcutis Biotherapeutics Hits New 52-Week High of $20.10, Up 162%

2025-10-02 22:41:22

Arcutis Biotherapeutics, Inc. achieved a new 52-week high of USD 20.10 on October 1, 2025, reflecting a significant performance increase over the past year. The company reported a 164.13% surge in net sales and has shown consistent growth with seven consecutive quarters of positive results.

Arcutis Biotherapeutics Achieves 101.39% Stock Surge, Establishing It as a Multibagger Performer

2025-10-01 17:13:44

Arcutis Biotherapeutics, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The company has achieved significant growth in net sales and operating cash flow, showcasing its operational strength and resilience in the Pharmaceuticals & Biotechnology sector.

Arcutis Biotherapeutics Hits New 52-Week High of $19.36

2025-10-01 16:44:40

Arcutis Biotherapeutics, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 2,080 million, has shown strong growth metrics, including a notable rise in net sales and consistent positive results over seven quarters.

Arcutis Biotherapeutics Hits Day High with Strong 7.29% Intraday Surge

2025-10-01 16:21:56

Arcutis Biotherapeutics, Inc. has shown impressive stock performance, with significant gains over various timeframes. The company reported a substantial increase in net sales and has achieved positive results for seven consecutive quarters. High institutional holdings further enhance its market position within the pharmaceuticals and biotechnology sector.

Is Arcutis Biotherapeutics, Inc. technically bullish or bearish?

2025-09-20 20:07:38

As of 12 August 2025, the technical trend for Arcutis Biotherapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view: the MACD is bullish on both weekly and monthly time frames, Bollinger Bands are bullish, and the On-Balance Volume (OBV) is also bullish. The daily moving averages confirm this bullish trend. However, the Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. In terms of performance, Arcutis has outperformed the S&P 500 over the past week (0.11% vs. 1.05%), month (5.79% vs. 2.33%), year-to-date (27.14% vs. 12.22%), and year (70.29% vs. 17.14%). However, it has underperformed over the longer 3-year and 5-year periods....

View All News